Subtopic Deep Dive
Focal Segmental Glomerulosclerosis
Research Guide
What is Focal Segmental Glomerulosclerosis?
Focal Segmental Glomerulosclerosis (FSGS) is a histologic pattern of glomerular injury characterized by focal and segmental sclerosis in glomeruli, leading to nephrotic syndrome and progressive kidney failure.
FSGS accounts for 40% of nephrotic syndrome cases in adults and up to 20% of dialysis patients. Pathologic variants include collapsing, hypertrophic, and cellular forms classified by D’Agati et al. (2004, 760 citations). Genetic forms involve TRPC6 mutations (Winn et al., 2005, 1080 citations) and circulating factors like suPAR (Wei et al., 2011, 830 citations).
Why It Matters
FSGS drives end-stage renal disease, with poor prognosis without early intervention; Savin et al. (1996, 709 citations) identified circulating permeability factors linked to post-transplant recurrence. Hebert et al. (2013, 4375 citations) provide diagnostic approaches distinguishing FSGS from other glomerulopathies. Therapeutic trials target podocyte homeostasis (Hartleben et al., 2010, 688 citations) and fibrosis pathways (Duffield, 2014, 600 citations), impacting 40% of adult nephrotic cases.
Key Research Challenges
Identifying Circulating Permeability Factors
Detecting elusive factors causing podocyte injury remains difficult, as shown by Savin et al. (1996, 709 citations) linking them to recurrent FSGS post-transplant. Wei et al. (2011, 830 citations) identified suPAR but assays lack specificity for clinical use.
Genetic Variant Classification
Distinguishing primary genetic FSGS from secondary forms challenges diagnosis; Winn et al. (2005, 1080 citations) reported TRPC6 mutations in familial cases. Routine screening for podocin or TRPC6 variants is not standardized across labs.
Pathologic Variant Differentiation
Classifying collapsing versus hypertrophic FSGS requires expert pathology; D’Agati et al. (2004, 760 citations) proposed a working system but inter-observer variability persists. Hebert et al. (2013, 4375 citations) emphasize biopsy timing in differential diagnosis.
Essential Papers
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Lee A. Hebert, Samir M. Parikh, Jason Prosek et al. · 2013 · American Journal of Nephrology · 4.4K citations
<b><i>Background:</i></b> Glomerular disease is a complex and evolving topic. In evaluating a specific case it is not unusual for the clinician to ask: ‘Am I missing somethi...
A Mutation in the <i>TRPC6</i> Cation Channel Causes Familial Focal Segmental Glomerulosclerosis
Michelle P. Winn, Peter J. Conlon, Kelvin L. Lynn et al. · 2005 · Science · 1.1K citations
Focal and segmental glomerulosclerosis (FSGS) is a kidney disorder of unknown etiology, and up to 20% of patients on dialysis have been diagnosed with it. Here we show that a large family with here...
Nephrotic syndrome in childhood
Allison A. Eddy, Jordan M. Symons · 2003 · The Lancet · 940 citations
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
Changli Wei, Shafic El Hindi, Jing Li et al. · 2011 · Nature Medicine · 830 citations
Pathologic classification of focal segmental glomerulosclerosis: a working proposal
Vivette D. D’Agati, Agnes B. Fogo, Jan A. Bruijn et al. · 2004 · American Journal of Kidney Diseases · 760 citations
Circulating Factor Associated with Increased Glomerular Permeability to Albumin in Recurrent Focal Segmental Glomerulosclerosis
Virginia J. Savin, Ram Sharma, Mukut Sharma et al. · 1996 · New England Journal of Medicine · 709 citations
A circulating factor found in some patients with focal segmental glomerulosclerosis is associated with recurrent disease after renal transplantation and may be responsible for initiating the renal ...
Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice
Björn Hartleben, Markus Gödel, Catherine Meyer‐Schwesinger et al. · 2010 · Journal of Clinical Investigation · 688 citations
Injury and loss of podocytes are leading factors of glomerular disease and renal failure. The postmitotic podocyte is the primary glomerular target for toxic, immune, metabolic, and oxidant stress,...
Reading Guide
Foundational Papers
Start with Hebert et al. (2013, 4375 citations) for glomerular differential diagnosis; D’Agati et al. (2004, 760 citations) for FSGS classification; Winn et al. (2005, 1080 citations) for genetic basis.
Recent Advances
Study Wei et al. (2011, 830 citations) on suPAR; Duffield (2014, 600 citations) on fibrosis mechanisms; Huang et al. (2023, 542 citations) on anti-fibrotic therapies.
Core Methods
Core techniques: electron microscopy for podocyte effacement (Hartleben et al., 2010); genetic mutation analysis (Winn et al., 2005); serum assays for permeability factors (Savin et al., 1996; Wei et al., 2011).
How PapersFlow Helps You Research Focal Segmental Glomerulosclerosis
Discover & Search
Research Agent uses searchPapers and citationGraph to map FSGS literature from Hebert et al. (2013, 4375 citations), revealing 50+ connected papers on glomerular diagnosis. exaSearch uncovers recent suPAR studies beyond OpenAlex; findSimilarPapers extends to TRPC6 variants from Winn et al. (2005).
Analyze & Verify
Analysis Agent applies readPaperContent to extract podocyte mechanisms from Hartleben et al. (2010), then verifyResponse with CoVe checks claims against 10 similar papers. runPythonAnalysis performs statistical meta-analysis of citation networks or suPAR levels; GRADE grading scores evidence strength for circulating factor assays.
Synthesize & Write
Synthesis Agent detects gaps in genetic FSGS therapies via contradiction flagging across Winn et al. (2005) and Wei et al. (2011). Writing Agent uses latexEditText, latexSyncCitations for FSGS review manuscripts, and latexCompile for publication-ready PDFs; exportMermaid visualizes pathologic classification trees from D’Agati et al. (2004).
Use Cases
"Meta-analyze suPAR levels in FSGS recurrence cohorts from 10 papers"
Research Agent → searchPapers + findSimilarPapers (Wei et al. 2011) → Analysis Agent → readPaperContent + runPythonAnalysis (pandas meta-analysis of levels/ORs) → CSV export of pooled statistics.
"Draft LaTeX review on TRPC6 mutations in familial FSGS"
Research Agent → citationGraph (Winn et al. 2005) → Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations + latexCompile → PDF with cited bibliography.
"Find GitHub code for podocyte autophagy simulations"
Research Agent → paperExtractUrls (Hartleben et al. 2010) → Code Discovery → paperFindGithubRepo + githubRepoInspect → verified simulation scripts for mTOR/podocyte modeling.
Automated Workflows
Deep Research workflow conducts systematic FSGS review: searchPapers (50+ glomerular papers) → citationGraph → GRADE evidence tables on variants. DeepScan applies 7-step analysis to biopsy classification from D’Agati et al. (2004), with CoVe checkpoints. Theorizer generates hypotheses linking suPAR (Wei et al., 2011) to fibrosis (Duffield, 2014).
Frequently Asked Questions
What defines Focal Segmental Glomerulosclerosis?
FSGS is focal and segmental glomerular sclerosis causing nephrotic syndrome, with variants like collapsing and hypertrophic (D’Agati et al., 2004, 760 citations).
What are key methods in FSGS research?
Methods include pathologic classification (D’Agati et al., 2004), genetic sequencing for TRPC6 (Winn et al., 2005), and suPAR assays for permeability factors (Wei et al., 2011).
What are seminal FSGS papers?
Hebert et al. (2013, 4375 citations) for diagnosis; Winn et al. (2005, 1080 citations) for TRPC6; Savin et al. (1996, 709 citations) for circulating factors.
What open problems exist in FSGS?
Challenges include specific circulating factor isolation beyond suPAR, standardized genetic screening, and variant-specific therapies preventing fibrosis progression.
Research Renal Diseases and Glomerulopathies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Focal Segmental Glomerulosclerosis with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers